DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

40.55 0.33 (0.82%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACAD $40.55 0.82%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.29
Previous Close $40.22
Daily Range $40.19 - $40.80
52-Week Range $19.15 - $46.48
Market Cap $4.1B
P/E Ratio -34.67
Dividend (Yield) $0.00 (0.0%)
Volume 802,654
Average Daily Volume 1,434,394
Current FY EPS -$1.26

Sector

Healthcare

Industry

Drug Makers

ACADIA Pharmaceuticals, Inc. (ACAD) Description

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Website: http://www.acadia-pharm.com/

News & Commentary Rss Feed

3 Stocks That Could Double Your Money

These three companies have the potential to double their share price from current levels. Here's why.

Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter

Acadia Pharmaceuticals Moves Up In Market Cap Rank, Passing QEP Resources

ACADIA Pharmaceuticals (ACAD) Q1 2015 Results - Earnings Call Webcast

Trade-Ideas: ACADIA Pharmaceuticals (ACAD) Is Today's Post-Market Leader Stock

Next Week In Biotech: Earnings Deluge - From GSK And Achillion To Intercept And Vivus

Benzinga's Top Initiations

Acadia Will Outperform, Worth $48/Share Says Leerink

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, Coach, Etsy, Intel, MannKind, Netflix, S

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, Coach, Etsy, Intel, MannKind, Netflix, SanDisk, Starbucks and More

Health Care Sector Update for 04/16/2015: ACAD, RCPT, HZNP

See More ACAD News...

ACAD's Top Competitors

ACAD $40.55 (0.82%)
Current stock: ACAD
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB